Jiang hua Yang | Medicine and Dentistry | Best Researcher Award

Dr. Jianghua Yang | Medicine and Dentistry | Best Researcher Award

Yijishan Hospital | China

Author Profile

Scopus

Early Academic Pursuits

Dr. Jianghua Yang began his academic journey in the medical field with a focus on infectious diseases. His foundational studies laid the groundwork for a career dedicated to understanding and combating a variety of infectious diseases. Over the years, Dr. Yang has honed his expertise and developed a deep research interest in several key areas, including tuberculosis, severe fever with thrombocytopenia syndrome, schistosomiasis, and hepatitis.

Professional Endeavors

Dr. Jianghua Yang is currently associated with the Department of Infectious Diseases at Yijishan Hospital of Wannan Medical College in Wuhu, Anhui, China. In his professional role, he has undertaken significant research projects and contributed extensively to the field of infectious diseases. His work is characterized by a commitment to advancing medical knowledge and improving patient outcomes through rigorous scientific inquiry and collaboration with other researchers.

Contributions and Research Focus

Dr. Yang's research spans several critical areas in infectious diseases. His studies on tuberculosis have been published in reputable journals such as "Tuberculosis (Edinb)" and the "International Journal of Infectious Diseases". His work on severe fever with thrombocytopenia syndrome has appeared in the "Journal of Medical Virology" and the "Japanese Journal of Infectious Diseases". Additionally, Dr. Yang has investigated schistosomiasis, with his findings published in "Scientific Reports" and "Journal of Cancer". His research on hepatitis has been featured in the "European Journal of Gastroenterology & Hepatology" and "BMC Gastroenterology". These contributions have not only enhanced the understanding of these diseases but have also provided valuable insights into their diagnosis, treatment, and management.

Accolades and Recognition

Throughout his career, Dr. Yang has received recognition for his impactful research and contributions to the field of infectious diseases. His publications have been cited by peers, reflecting the significance and influence of his work. Dr. Yang's dedication to advancing medical science has earned him respect and acknowledgment within the academic and medical communities.

Impact and Influence

Dr. Yang's research has had a substantial impact on the understanding and treatment of infectious diseases. His work on tuberculosis and severe fever with thrombocytopenia syndrome has informed clinical practices and guided further research in these areas. By elucidating the complexities of diseases such as schistosomiasis and hepatitis, Dr. Yang has contributed to the development of more effective diagnostic and therapeutic strategies, thereby improving patient care and outcomes.

Legacy and Future Contributions

Dr. Jianghua Yang's legacy in the field of infectious diseases is marked by his significant research contributions and his commitment to advancing medical knowledge. As he continues his work, Dr. Yang is poised to make further groundbreaking discoveries that will enhance the understanding of infectious diseases and lead to better health outcomes worldwide. His ongoing research and dedication to scientific excellence will undoubtedly inspire future generations of researchers and healthcare professionals.

 

Notable Publications

Trends of type 2 diabetes with pulmonary tuberculosis patients,2013–2022, and changes after the coronavirus disease 2019 (COVID-19) pandemic 2024 (2)

Construction of an early differentiation diagnosis model for patients with severe fever with thrombocytopenia syndrome and hemorrhagic fever with renal syndrome 2024

Prevalence and impact of viral myocarditis in patients with severe fever with thrombocytopenia syndrome 2024

Clinicopathological characteristics and its association with digestive system tumors of 1111 patients with Schistosomiasis japonica 2023 (1)

A risk prediction model for acute kidney injury in patients with pulmonary tuberculosis during anti-tuberculosis treatment 2022 (4)

 

 

 

 

 

Sanita Maleskic Kapo | Medicine and Dentistry | Best Researcher Award

Dr. Sanita Maleskic Kapo | Medicine and Dentistry | Best Researcher Award

University of Sarajevo | Bosnia and Herzegovina

Author Profile

Google Scholar

Early Academic Pursuits

Sanita Maleskic Kapo began her academic journey at the University of Sarajevo, delving into Pharmacology, Clinical Pharmacology, and Toxicology, culminating in her medical doctorate. Her formative years as a general practitioner at the Primary Health Care Center in Bihać enriched her understanding of patient care and community health.

Professional Endeavors

Transitioning into academia, she embraced teaching roles at the Faculty of Medicine, Sarajevo. Starting as a teaching assistant, her dedication and expertise elevated her to the position of Senior Teaching Assistant. Simultaneously, she embarked on a journey towards a Ph.D. in Pharmacology, further deepening her scholarly pursuits. Additionally, her ongoing residency in Clinical Pharmacology amplifies her practical acumen in the field.

Contributions and Research Focus

Sanita's contributions extend across academia and clinical practice. Her research focus in Pharmacology and Clinical Toxicology underscores her commitment to advancing medical knowledge. This commitment is reflected in her concurrent pursuit of a Ph.D. and residency, showcasing a dedication to scholarly and practical excellence.

Accolades and Recognition

Sanita Maleskic Kapo's journey is enriched by her notable accomplishments and dedication, marking her as a standout professional. While specific accolades may not be explicitly outlined, her multifaceted roles and continued academic progression underscore her recognition within the academic and medical spheres.

Impact and Influence

Her impact resonates through her teaching engagements, shaping future medical professionals. Simultaneously, her research endeavors lay the groundwork for advancements in Pharmacology and Clinical Toxicology, potentially influencing medical practices and patient care.

Legacy and Future Contributions

Sanita's legacy lies in her multifaceted contributions to academia, clinical research, and patient care. Her continued pursuit of a Ph.D. and residency promises a future where her expertise will further illuminate the realms of Pharmacology and Clinical Toxicology, potentially leaving an indelible mark in the field.

Notable Publications

Metformin use associated with protective effects for ocular complications in patients with type 2 diabetes - observational study 2017 (27)

Bioanthropological analysis of human occipital condyles using geometric morphometric method 2020 (5)

Analysis of gender differences on pyriform aperture of human skulls using geometric morphometric method 2021 (5)

Effects of topically applied diclofenac and ketoprofen on prostaglandin E2 and Stat3 sera levels and body temperature in two different acute inflammation models in rats 2021 (2)

Evaluation of long-term efficacy of disease-modifying agents in patients with relapsing-remitting multiple sclerosis 2019 (1)